Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17131.08 -49.10 NIFTY 5090.55 -13.00

Cadila Healthcare

BSE: 532321  |  NSE: CADILAHC  |  ISIN: INE010B01019  |  Pharmaceuticals
    
 

Have a tip or information to share on Cadila Healthcare?


Message   Positive opinion   Negative opinion   Query   Grievance   
View by : 
Latest Messages   |   Most Active   |   Top Rated   |   Top Tracked   |   Active Boarders
Go to page:   1    2    3    4    5    6    Next  [  ]    
Sort by:   
Positive Opinions   |   Negative Opinions   |   Queries   |   Grievances   |   ALL
27 Oct 2009 12:46

NSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 556.00 NSE:Rs. 238.15 when posted]

Cadila Healthcare Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 91258 lacs for quarter ending on 30-SEP-2009 against Rs. 73785 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 13192 lacs for the quarter ending on 30-SEP-2009 against Rs. 9488 lacs for the quarter ending on 30-SEP-2008....

27 Oct 2009 12:37

Qr Sept`09 Outstanding esult

Posted by : rvk41
Price when posted : BSE: Rs 551.15 ( 0.89 % ), NSE: Rs. 550.20 ( 0.18 % )

The Company has posted a net profit of Rs 1244.00 million for the quarter ended September 30, 2009 where as the same was at Rs 955.00 million for the quarter ended September 30, 2008. Total Income is Rs 6550.60 million for the quarter ended September 30, 2009 where as the same was at Rs 5533.30 million for the quarter ended September 30, 2008.

The Standalone figures of Cadila Healthcare Ltd. for the current quarter are not comparable with the figures of corresponding quarter of previous year because of demerger of Consumer Product Division, which got merged with Zydus Wellness Ltd, a subsidiary of Cadila Healthcare Ltd.

The Unaudited Consolidated Results are as follows

The Group has posted a net profit of Rs 1319.20 million for the quarter ended September 30, 2009 as compared to Rs 948.80 million for the quarter ended September 30, 2008. Total Income has increased from Rs 7436.50 million for the quarter ended September 30, 2008 to Rs 9498.90 million for the quarter ended September 30, 2009.

For information,with regards
rvk41...

27 Oct 2009 12:20

NSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 549.80 NSE:Rs. 238.15 when posted]

Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 27, 2009, titled "Zydus Cadila registers 39% increase in Net Profit in Q2". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...

27 Oct 2009 11:53

BSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 555.00 NSE:Rs. 238.15 when posted]

Cadila Healthcare Ltd has announced the following Unaudited results for the quarter ended September 30, 2009:

The Company has posted a net profit of Rs 1244.00 million for the quarter ended September 30, 2009 where as the same was at Rs 955.00 million for the quarter ended September 30, 2008. Total Income is Rs 6550.60 million for the quarter ended September 30, 2009 where as the same was at Rs 5533.30 million for the quarter ended September 30, 2008.

The Standalone figures of Cadila Healthcare Ltd. for the current quarter are not comparable with the figures of corresponding quarter of previous year because of demerger of Consumer Product Division, which got merged with Zydus Wellness Ltd, a subsidiary of Cadila Healthcare Ltd.

The Unaudited Consolidated Results are as follows

The Group has posted a net profit of Rs 1319.20 million for the quarter ended September 30, 2009 as compared to Rs 948.80 million for the quarter ended September 30, 2008. Total Income has increased from Rs 7436.50 million for the quarter ended September 30, 2008 to Rs 9498.90 million for the quarter ended September 30, 2009. ...

27 Oct 2009 11:48

BSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 555.00 NSE:Rs. 238.15 when posted]

Cadila Healthcare Ltd has informed BSE regarding a Press Release dated October 27, 2009 titled "Zydus Cadila registers 39% increase in Net Profit in Q2". ...

16 Oct 2009 13:05

Accmulate Cadila

Posted by : sam_pd
Price when posted : BSE: Rs 550.00 ( 1.22 % ), NSE: Rs. 550.10 ( 0.82 % )

exited 25 % of holding at 546...

23 Sep 2009 17:19

NSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 490.00 NSE:Rs. 238.15 when posted]

Cadila Healthcare Limited has informed the Exchange that CRISIL has, after due consideration, reaffirmed the P1+" (pronounced "P one plus") rating for the 1,250 million Short Term Debt Programme of the Company. This indicates that the degree of safety with regard to timely payment of interest and principal on the instrument is very strong....

23 Sep 2009 17:07

BSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 490.00 NSE:Rs. 238.15 when posted]

Cadila Healthcare Ltd has informed BSE that CRISIL has, after due consideration, reaffirmed the P1+" (pronounced "P one plus") rating for the 1,250 million Short Term Debt
Programme of the Company. This indicates that the degree of safety with regard to
timely payment of interest and principal on the instrument is very strong....

23 Sep 2009 16:12

BSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 490.00 NSE:Rs. 238.15 when posted]

Cadila Healthcare Ltd has informed BSE regarding the letter dated September 22, 2009 issued by CRISIL, reviewing of Rating for the Rs. 1,250 million Short Term Debt Programme of the Company. ...

16 Sep 2009 17:42

Bio-technology plant at Rs 250 mn

Posted by : rvk41
Price when posted : BSE: Rs 498.00 ( 1.15 % ), NSE: Rs. 494.75 ( 0.48 % )

Cadila Healthcare will establish a bio-technology plant with an investment of Rs 250 million for manufacturing biosimilars, reports Economic Times.

Biosimilars or follow on biologics are terms used to describe officially approved new version of innovator bio-pharmaceutical products following patent expiry.

The market of biologics has been projected to grow at 23% of the world pharma market by 2013.

Biologics include a wide range of medicinal products such as vaccines, blood and blood components, allergenic and recombinant therapeutic protein created by biological process

For information,with regards
rvk41...

08 Sep 2009 15:53

NSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 495.00 NSE:Rs. 238.15 when posted]

Cadila Healthcare Limited has submitted to the Exchange a copy of presentation proposed to be made by Chairman and Managing Director Mr. Pankaj R. Patel to the Institutional Investors. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).....

08 Sep 2009 15:34

A great rally

Posted by : LEO THE LION
Price when posted : BSE: Rs 495.00 ( -1.05 % ), NSE: Rs. 496.00 ( -0.89 % )

really.................

08 Sep 2009 15:24

A great rally

Posted by : tara23
Price when posted : BSE: Rs 490.00 ( -2.05 % ), NSE: Rs. 492.95 ( -1.50 % )

we cannot do anything except to see and enjoy.....

08 Sep 2009 13:12

A great rally

Posted by : LEO THE LION
Price when posted : BSE: Rs 486.00 ( -2.85 % ), NSE: Rs. 485.10 ( -3.07 % )

no........
while opened, locked at ckt level. how can we place a buy order......?...

08 Sep 2009 11:35

A great rally

Posted by : tara23
Price when posted : BSE: Rs 496.00 ( -0.85 % ), NSE: Rs. 494.00 ( -1.29 % )

ok... could have posted yesterday for an entry today? missed thepost....